5 Key Takeaways
-
1
Surgeon hesitation significantly limits the adoption of minimally invasive glaucoma surgery (MIGS) despite patient acceptance.
-
2
Nearly half of glaucoma patients undergoing cataract surgery do not receive concomitant glaucoma treatment.
-
3
Some surgeons avoid MIGS due to discomfort with gonioscopy or a preference to refer glaucoma patients to colleagues.
-
4
Emerging treatments, such as direct selective laser trabeculoplasty and intraocular drug-delivery platforms, may increase accessibility for surgeons.
-
5
New glaucoma treatment options are being developed to accommodate surgeons hesitant about gonioscopy, benefiting patient care.
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.







